影响因子从3分一路猛涨到15+分!最近4篇文章被曝光疑有问题!

2020-07-28 11:03:39 浏览数 (1)

这年头,造假翻车屡见不鲜,这高分段杂志期刊翻车较为少见!

这不,2020年最新IF为15.302Molecular Cancer,居然翻车了!

什么,你居然还不认识Molecular Cancer?

这涨分速度!

图源:选刊说公众号

发表最多的机构为德州大学(105篇, 4.390%),其次是中山大学(90篇, 3.763%),上海交通大学(84篇, 3.512%),还有我国其他机构均占有一定的比例,如南京医科大学,复旦大学,浙江大学,中科院,南方医科大学等。

Citescore排名顶尖,排名均在97%

图源:选刊说公众号

日前,著名学术打假网站 Pubpeer挂了来自Molecular Cancer的论文,发表单位均来自于国内著名科研单位~~

这好不容易涨到15分的论文呀,突然被打假

━((*′д`)爻(′д`*))━!!!!

第一篇

Title:Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis

Affiliations: 中山大学孙逸仙纪念医院

① Department of Urology and Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107th Yanjiangxi Road, Yuexiu District, Guangzhou 510120, China

质疑:一图多用 (Figure 8e)

回应状态:作者尚未回应

第二篇

Title:CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling

Affiliations: 上海交大附属第六人民医院

①Department of Gastroenterology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600 Yishan Road, Shanghai, 200233, China.

②Department of Gastroenterology, Shanghai Ninth People's Hospital, Shanghai Jiao ③Tong University School of Medicine, Shanghai, China. ④Department of Gastroenterology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600 Yishan Road, Shanghai, 200233, China.

质疑:Figure 7 appears to have a duplicate image for different cell lines (一图多用)

回应状态:作者已回应,表示将仔细检查论文原始数据

图源: Pubpeer

第三篇

Title:CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p

Affiliations: 南京市第一医院 南京医科大学附属南京医院

①Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.

②Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.

③Department of General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.

④Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.

质疑:Figure 5h appears to use the same image 3 times for different cell lines(一图多用)

回应状态:作者尚未回应

图源: Pubpeer

第四篇

Title:EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis

Affiliations: 中国人民武装警察部队特色医学中心

①Institute of Traumatic Brain Injury and Neurology, Characteristic Medical Center of Chinese People’s Armed Police Force, Tianjin 300162, China.

②Department of Neurosurgery, Characteristic Medical Center of Chinese People’s Armed Police Force, Tianjin 300162, China.

③Department of Basic Medicine, Tianjin Medical College, Tianjin 300222, China.

④Chinese Glioma Cooperative Group (CGCG), Tianjin, China.

质疑:一图多用;此外,还有如下问题:

① miR-124的引物实际上是CDK4的引物

② AURK的引物是双歧杆菌基因的引物

③ circMMP9的长度应为为312 bp,而此文章中长度居然是540bp!!!

回应状态:作者尚未回应

此外,我们来看看,最近Molecular Cancer发表的一些文章,还是很多是属于非编码RNA:

  • RNA的N6-甲基腺苷修饰在人类癌症中的作用机制

Received: 31 January 2020 Accepted: 13 May 2020 Online: 08 June 2020 从投稿到接受3.4个月

  • CircTLK1通过刺激miR-136-5p促进肾细胞癌的增殖和转移

Received: 11 November 2019 Accepted: 28 May 2020 Online: 05 June 2020 从投稿到接受6.6个月

  • 环状RNA circSATB2促进非小细胞肺癌细胞的进程

Received: 26 August 2019 Accepted: 21 May 2020 Online: 03 June 2020 从投稿到接受9个月

  • 环状RNA circMET通过miR-30-5p / snail / DPP4轴驱动肝细胞癌的免疫抑制和抗PD1治疗耐药性

Received: 29 November 2019 Accepted: 07 May 2020 Online: 19 May 2020 从投稿到接受5.3个月

  • 发现新型第三代EGFR抑制剂并确定克服其耐药性的潜在联合策略

Received: 26 November 2019 Accepted: 15 April 2020 Online: 13 May 2020 从投稿到接受4.7个月

  • LncRNA TROJAN在ER 乳腺癌中通过激活CDK2转录促进细胞增殖和对CDK4/6抑制剂的抵抗

Received: 02 December 2019 Accepted: 27 April 2020 Online: 11 May 2020 从投稿到接受4.9个月 来自:选刊说公众号

截至发稿,目前这几篇文章的作者大部分都未进一步回应,那咱们就静观其变。

0 人点赞